China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research report report published on Wednesday morning. The firm issued a hold rating on the stock.

China Pharma Stock Performance

China Pharma stock opened at $0.23 on Wednesday. The company’s 50 day simple moving average is $0.21 and its 200 day simple moving average is $0.22. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. China Pharma has a fifty-two week low of $0.13 and a fifty-two week high of $0.60.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.